The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Value
|
96 | 70 | 39 | 41 |
|
Growth
|
28 | 21 | 21 | 23 |
|
Safety
|
98 | 98 | 100 | 100 |
|
Sentiment
|
30 | 42 | 67 | 19 |
|
360° View
|
82 | 64 | 70 | 39 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Analyst Opinions
|
1 | 1 | 1 | 10 |
|
Opinions Change
|
1 | 50 | 50 | 50 |
|
Pro Holdings
|
n/a | 46 | 71 | 50 |
|
Market Pulse
|
83 | 89 | 95 | 56 |
|
Sentiment
|
30 | 42 | 67 | 19 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Value
|
96 | 70 | 39 | 41 |
|
Growth
|
28 | 21 | 21 | 23 |
|
|
98 | 98 | 100 | 100 |
|
Combined
|
91 | 81 | 55 | 60 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Price vs. Sales (P/S)
|
91 | 63 | 34 | 61 |
|
Price vs. Earnings (P/E)
|
97 | 85 | 73 | 70 |
|
Price vs. Book (P/B)
|
73 | 53 | 43 | 14 |
|
Dividend Yield
|
1 | 1 | 1 | 1 |
|
Value
|
96 | 70 | 39 | 41 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Revenue Growth
|
6 | 60 | 16 | 11 |
|
Profit Growth
|
43 | 14 | 27 | 32 |
|
Capital Growth
|
88 | 51 | 53 | 51 |
|
Stock Returns
|
14 | 23 | 53 | 83 |
|
Growth
|
28 | 21 | 21 | 23 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Leverage
|
78 | 78 | 100 | 100 |
|
Refinancing
|
76 | 80 | 61 | 29 |
|
Liquidity
|
100 | 100 | 100 | 100 |
|
|
98 | 98 | 100 | 100 |
Discover high‑ranked alternatives to USANA Health Sciences and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.
30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.